Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.07 USD | -1.78% | -4.23% | -2.50% |
Jun. 10 | Latest trial over Zantac cancer claims called off as plaintiff drops case | RE |
Jun. 10 | Pfizer to Pause Sizable Acquisitions as it Integrates Existing Investments, CEO Says | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.50% | 162B | |
+48.39% | 765B | |
-6.13% | 354B | |
+20.61% | 331B | |
+10.00% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.80% | 164B | |
+0.57% | 123B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Redburn Atlantic Adjusts Price Target on Pfizer to $27 From $26, Keeps Neutral Rating